PLCG1 and triple-A syndrome: Consistent with mRNA studies (Figure 1), AAA tissue showed no staining against PLCG1 antibody, while control tissue had ubiquitous staining in endothelial cells of the vasa vasorum and in the vascular smooth muscle cells (VSMCs) (Figure 2).